Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd Breeze Pocket BR.

Sanofi1 site in 1 country54 target enrollmentOctober 2008

ConditionsHygiene

InterventionsLactic Acid

DrugsLactic Acid

Overview

Phase: Phase 3
Intervention: Lactic Acid
Conditions: Hygiene
Sponsor: Sanofi
Enrollment: 54
Locations: 1
Primary Endpoint: The absence of primary and accumulated dermical irritability and dermical sensitivity will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale.
Status: Completed
Last Updated: 17 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Sites Similar Trials

Overview

Brief Summary

To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Breeze (Lactic Acid) Pocket BR.

Registry

clinicaltrials.gov

Start Date

October 2008

End Date

November 2008

Last Updated

17 years ago

Study Type

Interventional

Study Design

Single Group

Sex

Female

Investigators

Sponsor

Sanofi

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Arms & Interventions

1

Lactic Acid (Dermacyd Breeze)

Intervention: Lactic Acid

Outcomes

Primary Outcomes

The absence of primary and accumulated dermical irritability and dermical sensitivity will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale.

Time Frame: Throughout the study